Cover Image
市場調查報告書

社區型肺炎(CAP):全球臨床實驗檢討

Community Acquired Pneumonia Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 320348
出版日期 內容資訊 英文 103 Pages
訂單完成後即時交付
價格
Back to Top
社區型肺炎(CAP):全球臨床實驗檢討 Community Acquired Pneumonia Global Clinical Trials Review, H2, 2014
出版日期: 2014年11月28日 內容資訊: 英文 103 Pages
簡介

社區型肺炎(CAP)是臨床醫生臨診中最常見的傳染病之一。CAP是全球死亡率與罹患率的重要原因。許多病原體都可能引發CAP。引起症狀的代表性細菌性病原體為肺炎球菌(penicillin敏感性、penicillin抗藥性)、流行性感冒嗜血桿菌(Ampicillin敏感性、Ampicillin抗藥性)、卡他莫拉菌(moraxella catarrhalis,MC)(全都是penicillin抗藥性)。這三種病原體約佔CAP病例的85%。CAP一般由肺部一區或肺葉吸入肺的病原菌細菌造成感染。雖然不常見,但也有可能引發大腸菌的泌尿道感染或菌血症、二次菌血症等併發症。誤嚥性肺炎是由複數的病原體(例如好氧/厭氧口腔內微生物)引發的唯一型態。

本報告提供社區型肺炎(CAP)的治療藥相關之臨床實驗調查分析,提供您臨床實驗數及受驗人數,各階段及Phase狀況,有潛力的企業,正在開發的治療藥資訊,臨床實驗簡介等相關的系統性資訊。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中東·非洲的主要國家
    • 中南美的主要國家

G7各國的臨床實驗:感染性疾病臨床實驗上社區型肺炎(CAP)所佔的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:各階段

E7各國的臨床實驗:感染性疾病臨床實驗上社區型肺炎(CAP)所佔的比例

E7各國的臨床實驗:Phase別

E7各國的臨床實驗:各階段

Phase別臨床實驗

各階段臨床實驗

評估項目別臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對象

贊助商類別臨床實驗

有潛力的贊助商

  • 社區型肺炎(CAP)的治療藥臨床實驗之主要參與企業

有潛力藥物

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Pfizer Inc.
    • TaiGen Biopharmaceuticals Holdings Limited
    • Sanofi
    • Actavis plc
    • Bayer AG
    • Melinta Therapeutics, Inc
    • Novartis AG
    • GlaxoSmithKline plc
    • AstraZeneca PLC
    • Abbott Laboratories
  • 主要大學·研究機關·醫院臨床實驗概要
    • St. Antonius Hospital
    • University Hospital Basel
    • University of Milan
    • HaEmek Medical Center
    • Medical Center Alkmaar
    • Spanish National Health System
    • Carlos III Health Institute
    • Nagasaki Evaluation Organization for Clinical Interventions
    • 小野市立小野市民醫院
    • University of Roma La Sapienza

主要的臨床簡介

附錄

圖表

目錄
Product Code: GDHC2435CTIDB

GlobalData's clinical trial report, "Community Acquired Pneumonia Global Clinical Trials Review, H2, 2014" provides data on the Community Acquired Pneumonia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Community Acquired Pneumonia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Community Acquired Pneumonia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Community Acquired Pneumonia
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Community Acquired Pneumonia
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Community Acquired Pneumonia Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Community Acquired Pneumonia
    • Oct 03, 2014: FDA Grants Durata Therapeutics a Special Protocol Agreement for Its Phase 3 Study of DALVANCE in Hospitalized Community-Acquired Pneumonia
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • TaiGen Biopharmaceuticals Holdings Limited
      • Clinical Trial Overview of TaiGen Biopharmaceuticals Holdings Limited
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Actavis plc
      • Clinical Trial Overview of Actavis plc
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Melinta Therapeutics, Inc
      • Clinical Trial Overview of Melinta Therapeutics, Inc
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Abbott Laboratories
      • Clinical Trial Overview of Abbott Laboratories
    • Clinical Trial Overview of Top Institutes / Government
      • St. Antonius Hospital
      • Clinical Trial Overview of St. Antonius Hospital
      • University Hospital Basel
      • Clinical Trial Overview of University Hospital Basel
      • University of Milan
      • Clinical Trial Overview of University of Milan
      • HaEmek Medical Center
      • Clinical Trial Overview of HaEmek Medical Center
      • Medical Center Alkmaar
      • Clinical Trial Overview of Medical Center Alkmaar
      • Spanish National Health System
      • Clinical Trial Overview of Spanish National Health System
      • Carlos III Health Institute
      • Clinical Trial Overview of Carlos III Health Institute
      • Nagasaki Evaluation Organization for Clinical Interventions
      • Clinical Trial Overview of Nagasaki Evaluation Organization for Clinical Interventions
      • Ono Municipal Hospital
      • Clinical Trial Overview of Ono Municipal Hospital
      • University of Roma La Sapienza
      • Clinical Trial Overview of University of Roma La Sapienza
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Region, 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Community Acquired Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Community Acquired Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Community Acquired Pneumonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Community Acquired Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Community Acquired Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by TaiGen Biopharmaceuticals Holdings Limited, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Melinta Therapeutics, Inc, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Antonius Hospital, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Milan, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by HaEmek Medical Center, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Center Alkmaar, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Spanish National Health System, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Carlos III Health Institute, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagasaki Evaluation Organization for Clinical Interventions, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ono Municipal Hospital, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Roma La Sapienza, 2014*

List of Figures

  • Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Community Acquired Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Community Acquired Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Community Acquired Pneumonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Community Acquired Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Community Acquired Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top